Pearla Awad: Liposomal Iron Is Better Tolerated, With Fewer Adverse Effects and Lower Constipation Rates
Pearla Awad, Student Council, Cardiology Society Research Officer at RCSI Medical University of Bahrain, shared on LinkedIn about a recent article she and her colleagues co-authored, published in European Journal of Pediatrics, adding:
”Proud to share our latest publication in the European Journal of Pediatrics:
‘Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: a systematic review and meta-analysis of randomized controlled trials.’
In this study, we analyzed data from four randomized controlled trials involving 454 pediatric patients.
We found that liposomal iron is better tolerated, with fewer adverse effects and lower rates of constipation, while delivering comparable, and in some cases greater, hematologic outcomes compared to conventional oral iron.
Have a read.
This project was a great opportunity to explore an evolving therapeutic approach in pediatric hematology and contribute to the growing evidence supporting liposomal iron formulations. Grateful to all co-authors and collaborators for their contributions and teamwork throughout this project.”
Title: Safety and efficacy of liposomal iron for iron deficiency anemia in pediatric population: A systematic review and meta-analysis of randomized controlled trials
Authors: Abdullah M. Alharran, Esraa Yousef Almutairi, Waleed Bader Alazemi, Fatemah Adel Alnejadah, Hasan S Hasan, Layal AlOufan, Asayel M Alsultan, Hala AlOmar, Maryam Alqayem, Joy Maasarani, Aljazi Alohaly, Pearla Awad, Abdullatif Alfehaid
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 6, 2026, 16:53Leonardo Roever: Can a Simple Cholesterol Ratio Predict Post-Stroke Depression?
-
Jun 6, 2026, 16:21Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
-
Jun 6, 2026, 15:26Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
-
Jun 6, 2026, 15:16Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
-
Jun 6, 2026, 15:14Julianne Chong: Components of Antithrombotic Stewardship Programs from an International Perspective
-
Jun 6, 2026, 15:13Vincent Ten Cate: The Largest Blood-Based EWAS of Atherosclerosis to Date
-
Jun 6, 2026, 14:48Eliminating DOAC Interference in Routine Coagulation Assays – JTH
-
Jun 6, 2026, 14:35Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
-
Jun 6, 2026, 14:30Alan Nurden: Honoring the Legacy of Dr. Richard Aster